ARCAD,/

Hideaki Bando1,2, Yuriko Takeda2, Toshihiro Misumi2

  • 1Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.

JNCI cancer spectrum
|April 25, 2025
PubMed
概括

早期瘤缩和反应深度是转移性结直肠癌 (CRC) 的关键预后指标. 这些指标预测了接受抗EGFR抗体或贝瓦齐祖马布的患者的结果,指导治疗策略.